Post-COVID-19 Long Hauler Clinical Program: Change in Health-Related Quality-of-Life

Background and Objective An Integrative Medicine Center created a post-COVID-19 myalgiac encephalomyelitis (ME) program in response to a July 2020 Centers for Disease Control and Prevention document that described fatigue and other functional symptoms. The objective is to present process improvement...

Full description

Saved in:
Bibliographic Details
Main Author: Marc Brodsky MD (Author)
Format: Book
Published: SAGE Publishing, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3bc3aae390c54d5a9a103c69ece46926
042 |a dc 
100 1 0 |a Marc Brodsky MD  |e author 
245 0 0 |a Post-COVID-19 Long Hauler Clinical Program: Change in Health-Related Quality-of-Life 
260 |b SAGE Publishing,   |c 2021-11-01T00:00:00Z. 
500 |a 2164-9561 
500 |a 10.1177/21649561211059082 
520 |a Background and Objective An Integrative Medicine Center created a post-COVID-19 myalgiac encephalomyelitis (ME) program in response to a July 2020 Centers for Disease Control and Prevention document that described fatigue and other functional symptoms. The objective is to present process improvement data on change in health-related quality-of-life (HRQOL) in patients who participated in the "long hauler" program. Methods For process improvement purposes, 39 consecutive patients who participated in the post-COVID-19 ME program from August 2020-August 2021 were asked to complete the 12-Item Short Form Survey (SF-12) before treatment and a month later. Results Twelve participants (31%) completed a baseline and follow-up survey. Mean SF-12 physical component summary scores improved 5 (SD 9) and mental component summary scores improved 4 (SD 9) in patients who completed baseline and follow-up surveys. Case studies of two patients who completed the SF-12 at baseline and after 4 weekly treatments illustrate the program's standardized treatment approach. Conclusion Data collected for process improvement reasons describe changes in HRQOL for participants in a post-COVID-19 ME program. Follow-up practice-based clinical trials may discern optimal approaches for patients with this chronic condition. 
546 |a EN 
690 |a Medicine (General) 
690 |a R5-920 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Global Advances in Health and Medicine, Vol 10 (2021) 
787 0 |n https://doi.org/10.1177/21649561211059082 
787 0 |n https://doaj.org/toc/2164-9561 
856 4 1 |u https://doaj.org/article/3bc3aae390c54d5a9a103c69ece46926  |z Connect to this object online.